Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Edwige Abeilard-Lemoisson"'
Autor:
Francisca Ong, Christophe Fruchart, Aspasia Stamatoullas, Marc André, Edwige Abeilard-Lemoisson, Jeanette K. Doorduijn, Evert M. Noordijk, Catherine Sebban, John M. M. Raemaekers, Brice Dubois, José Thomas, Christophe Fermé, Bart Meulemans, Marleen A. E. van der Kaaij, Serge Bologna, Michele Spina, Anouk Allgeier, W.M. Smit, Pauline Brice, Hanneke C. Kluin-Nelemans, Pieternella J. Lugtenburg, Isabelle Gaillard, Lotte C. Moser, Michel Henry-Amar, Paul Meijnders, Arnold Simons, Berthe M.P. Aleman, Judith M. Roesink, Natacha Heutte
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (31), pp.3854-3863. ⟨10.1200/JCO.2011.40.8906⟩
Journal of clinical oncology
Journal of Clinical Oncology, 30(31), 3854-3863. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 30, 3854-63
Journal of Clinical Oncology, 30(31), 3854-3863. American Society of Clinical Oncology
Journal of Clinical Oncology, 30, 31, pp. 3854-63
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (31), pp.3854-3863. ⟨10.1200/JCO.2011.40.8906⟩
Journal of clinical oncology
Journal of Clinical Oncology, 30(31), 3854-3863. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 30, 3854-63
Journal of Clinical Oncology, 30(31), 3854-3863. American Society of Clinical Oncology
Journal of Clinical Oncology, 30, 31, pp. 3854-63
Purpose We investigated the impact of Hodgkin lymphoma (HL) on parenthood, including factors influencing parenthood probability, by comparing long-term HL survivors with matched general population controls. Patients and Methods A Life Situation Quest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0998daf7d4dfc3a6beb54983abd97ba
https://hdl.handle.net/11370/6999bf96-22ab-4268-8eb5-4215d5164224
https://hdl.handle.net/11370/6999bf96-22ab-4268-8eb5-4215d5164224
Autor:
Charlotte, Lepleux, Edwige, Abeilard-Lemoisson, Maryline, Duval, Philippe, Icard, Hubert, Lincet
Publikováno v:
Anticancer research. 32(10)
Enhanced glycolysis provides essential intermediates for cancer cell proliferation. Its inhibition could be a promising approach for destroying tumors, especially those developing in hypoxic conditions, which are presumably the most chemoresistant. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f85a9ac1e7e3bf60616716ab67148719
https://pubmed.ncbi.nlm.nih.gov/23060548
https://pubmed.ncbi.nlm.nih.gov/23060548
Autor:
Berthe M.P. Aleman, Natacha Heutte, Jeanette K. Doorduijn, Elizabeth C. Moser, Hanneke C. Kluin-Nelemans, Pieternella J. Lugtenburg, Isabelle Gaillard, Serge Bologna, Michel Henry-Amar, Houchingue Eghbali, Franck Morschhauser, Marleen A. E. van der Kaaij, Arnold Simons, Catherine Sebban, Pauline Brice, Bart Meulemans, Marie Bouteloup, Christophe Fruchart, Paul Meijnders, Judith M. Roesink, John M. M. Raemaekers, Achiel Van Hoof, Christophe Fermé, Francisca Ong, José Thomas, Michele Spina, Anouk Allgeier, Aspasia Stamatoullas, Edwige Abeilard-Lemoisson, Evert M. Noordijk
Publikováno v:
Journal of clinical oncology
Journal of Clinical Oncology, 30, 291-9
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal of Clinical Oncology, 30, 3, pp. 291-9
Journal of Clinical Oncology, 30(3), 291-299. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal of Clinical Oncology, 30(3), 291-299. American Society of Clinical Oncology
Journal of Clinical Oncology, 30, 291-9
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal of Clinical Oncology, 30, 3, pp. 291-9
Journal of Clinical Oncology, 30(3), 291-299. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal of Clinical Oncology, 30(3), 291-299. American Society of Clinical Oncology
Purpose In this large cohort of Hodgkin's lymphoma survivors with long follow-up, we estimated the impact of treatment regimens on premature ovarian failure (POF) occurrence and motherhood, including safety of nonalkylating chemotherapy and dose-resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a802a5fb1b9696194c7d3c27005e2d2b
http://hdl.handle.net/1887/97656
http://hdl.handle.net/1887/97656
Autor:
Laurent Poulain, Perrine Kafara, Edwige Abeilard-Lemoisson, Florence Giffard, Maryline Duval, Marie-Hélène Louis, Hubert Lincet, Philippe Icard
Publikováno v:
Journal of Ovarian Research
The inhibition of two major anti-apoptotic proteins, Bcl-xL and Mcl-1, appears essential to destroy chemoresistant cancer cells. We have studied their concomitant inhibition, using ABT 737 or siRNA targeting XL1 and citrate, a molecule which reduces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14bac156f25c1a74e5819edaafe304d